# Regencell Bioscience Holdings Limited (RGC)

> Healthcare · HK · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RGC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -7.22M | $ 0 | $ 386.3K | $ 1.22M |
| 2024 | $ 0 | $ -1.95M | $ -2.11M | $ 0 | $ 6.72M |
| 2023 | $ 0 | $ -2.86M | $ -4.86M | $ 0 | $ 10.16M |
| 2022 | $ -2.62B | $ -8.01M | $ -6.17M | $ 0 | $ 14.66M |
| 2021 | $ 0 | $ -4.35M | $ -3.59M | $ 1.4K | $ 19.70M |
| 2020 | $ 0 | $ -539 | $ -550 | $ 3.54M | $ -2.98M |
| 2019 | $ 0 | $ -192 | $ -237 | $ 0 | $ -1.84M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.32 |
| Liabilities / Eq | 1.47 |
| Current Ratio | 1.42 |

## Other views

- [Metrics](https://sponda.capital/en/RGC.md)
- [Charts](https://sponda.capital/en/RGC/charts.md)
- [Compare](https://sponda.capital/en/RGC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.